拥有逾45年细胞级护肤历史的法国高端护肤品牌Galenic科兰黎，广州太古汇华南精品店于近日开业。 法国驻广州总领事馆商务投资处、中国法国工商会，以及太古汇(广州)发展有限公司等中法工商界、外交界及品牌核心伙伴的相关负责人出席 了活动。 法国科兰黎诞生于1978年，由知名医药及皮肤科学家皮尔·法伯博士在巴黎创立。皮尔·法伯博士专研医药科学、细胞生物学等领域数十年，开 创了皮肤学护肤品的先河，他本人则获得法国总统授予的荣誉勋章。 逾45年深耕中，品牌始终秉持"科技引领卓越"的理念，以医药领域靶向渗透科技为灵感，突破性研发细胞级锚点渗透科技ActiveAnchor，并基 于此打造能作用于细胞的卓越护肤配方。每款产品均经过三重医药科研实证，为全球不同女性带来更活性、更深层、更有效的抗老效果与护肤 体验。 南方+记者 李劼 作为深耕中国市场的国际品牌，科兰黎方面表示，品牌始终将全球领先的科技与本土消费者需求相结合，精品店的开设是对中国市场的长期承 诺，也标志着品牌在华战略布局的进一步深化。 ...

Investment Rating - The report does not explicitly state an investment rating for the industry or companies involved [5][6]. Core Insights - The 13th Committee's 8th Plenary Session successfully passed the "14th Five-Year Plan" development proposal, emphasizing the transformation direction of "five changes and one advancement" to convert various advantages into development momentum [5][11]. - The focus during the "14th Five-Year" period will be on four major directions to accelerate the construction of a new highland for opening up to the north, including deepening cooperation with Russia and expanding into diverse markets [12]. - The Black龙江板块 index experienced a significant adjustment, dropping 2.63% in November, with a notable decline of 7.31% from November 17 to 21, indicating a bearish market sentiment [21][24]. Summary by Sections Economic Development - The "14th Five-Year" plan outlines 15 parts and 62 articles, detailing development tasks across three major sectors, aiming for a modernized strong province [5][11]. - The province aims to enhance its international economic cooperation and optimize the foreign investment environment, promoting the "Investment Longjiang" brand [12]. Market Performance - The Black龙江板块 index has shown a downward trend, with only five companies achieving positive returns during the period from November 10 to 21, with People's Tongtai leading at a 37.59% increase [21][25]. - The overall performance of the listed companies was weak, with 23 companies experiencing declines of over 5%, and 8 companies seeing declines exceeding 10% [21][25]. Industry Insights - The report highlights the importance of collaboration with companies like UBTECH to enhance talent cultivation and industrial upgrading in the province, focusing on the application of humanoid robots in education [15]. - The province's economic data for the first three quarters of the year indicates a stable growth trend, supported by strong import and export performance [21].

Market Performance - The US hotel sector increased by 2.8%, with Marriott and Hilton rising by 3.8% and 1.83% respectively, demonstrating resilience under pressure[6] - The overseas sportswear sector decreased by 0.2%, with Amer Sports surging by 12.2% due to strong Q3 performance, leading to a revenue increase of 30%[14] - The jewelry sector fell by 2.1%, influenced by AI bubble concerns and reduced expectations for a December rate cut, strengthening the dollar[14] Sector Analysis - The domestic sportswear sector dropped by 2.4%, with major OEMs like Shenzhou International and Crystal International declining by 6.7% and 2.6% respectively due to geopolitical tensions[14] - The retail sector saw a decline of 4.0%, with China Duty Free falling by 10.5% as investors took profits amid uncertain policy outlooks[14] - The pet sector decreased by 5.7%, with concerns over sustainability as sales expenses outpaced revenue growth[14] Valuation Insights - The expected PE for the overseas sportswear sector in 2025 is 29.0x, which is 54% of the past 5-year average[15] - The expected PE for the domestic cosmetics sector is 27.6x, representing 52% of the past 5-year average[15] - Most sectors are valued below their historical 5-year averages, indicating potential investment opportunities[15]

Group 1 - A sudden cancellation of 500,000 tickets by Chinese travelers to Japan has led to a significant decline in Japanese consumer stocks, with Shiseido dropping 11.4%, the largest decline since April [1] - Major Japanese companies such as Fast Retailing and Muji saw their stock prices fall nearly 7% and over 9% respectively, while Japan Airlines experienced a drop of nearly 6% [1] - Japanese economic experts predict that a sharp decrease in Chinese tourists could result in losses exceeding 2 trillion yen for Japan [3] Group 2 - The Japan National Tourism Organization reported that from 2025's first three quarters, the number of Chinese tourists to Japan reached 7.487 million, a year-on-year increase of 42.7%, making China the largest source of inbound tourists to Japan [3] - In 2023, Japan issued 5.24 million visas to Chinese travelers, a 73% increase from the previous year, accounting for 70% of total visas issued [11] - Chinese tourists represented 18.9% of all foreign visitors to Japan, with a year-on-year growth of 187.9%, indicating that one in five foreign tourists in Japan is Chinese [13] Group 3 - The Chinese tourism industry is projected to contribute 13.7 trillion yuan to the global economy by 2025, accounting for 10.3% of global tourism GDP and creating 83 million jobs [5] - In 2023, Chinese tourists spent approximately 812 billion yuan in Japan, the highest among all countries, highlighting their significant economic impact [17] - The travel habits of Chinese tourists have led to increased demand for services and products tailored to their preferences in various countries, including Japan [27][29] Group 4 - The rapid growth of Chinese tourism is evident as they have become a major force in global travel, with 10 million Chinese tourists visiting Australia in January 2023, surpassing New Zealand as the largest source of overseas visitors [44] - Chinese tourists spend nearly double compared to New Zealand tourists, with an average expenditure of 5,081 AUD [45] - The presence of Chinese tourists has significantly boosted local economies, with prices in popular tourist areas rising dramatically due to increased demand [46][49]

丽人丽妆再度涨停，5个交易日内录得3个涨停，累计涨幅为11.35%，累计换手率为62.48%。截至 10:28，该股今日成交量3907.11万股，成交金额4.18亿元，换手率9.76%。最新A股总市值达44.77亿元。 龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%、日跌幅偏离值达7%上榜龙虎榜2 次，买卖居前营业部中，营业部席位合计净卖出433.19万元。 据天眼查APP显示，上海丽人丽妆化妆品股份有限公司成立于2010年05月27日，注册资本40045.85万人 民币。（数据宝） 近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.11.21 | -7.04 | 13.05 | -45.22 | | 2025.11.20 | -9.97 | 18.72 | -17034.89 | | 2025.11.19 | 9.96 | 13.17 | 1786.52 | | 2025.11.18 | 9.96 | 7.79 | 15969.10 | | 2025.11.17 | 2.14 | ...

Core Viewpoint - The domestic skincare brand "Plant Doctor" is aiming to become the first single-brand beauty stock listed on A-shares, with plans to raise 998 million yuan through an IPO on the Shenzhen Stock Exchange, despite facing significant internal control issues that have delayed its listing process by 19 months [1][2]. Financial Performance - Plant Doctor's revenue has stagnated around 2.1 billion yuan from 2022 to 2024, with an average annual compound growth rate of less than 1% [1][5]. - The company's net profit has shown slight growth, with figures of 158 million yuan, 230 million yuan, and 243 million yuan for the respective years, but the growth rate has significantly slowed down [6]. Marketing and R&D Expenditure - Over the past three years, Plant Doctor has spent a total of 2.16 billion yuan on R&D, which is only 10.12 times less than its marketing expenses of 21.85 billion yuan [5][7]. - The marketing expenses accounted for over 34% of annual revenue from 2022 to 2024, while R&D investment remained below 4% of revenue during the same period [7]. Internal Control Issues - The company has faced significant internal control deficiencies, particularly in managing franchisees, leading to issues such as non-compliance in sales practices and product quality [2][4]. - As of November 23, 2023, there were 311 complaints against Plant Doctor on the Black Cat Complaints platform, primarily related to forced sales, allergic reactions to products, and difficulties in after-sales service [3]. Product Quality Concerns - Plant Doctor has faced multiple quality control issues, including a product that exceeded the allowable bacterial count by 21 times, leading to a recall and further damaging consumer trust [2][3]. - The company has received penalties from regulatory bodies for various violations, including price fraud and lack of hygiene permits for some stores [4]. Store Network and Franchise Model - As of the end of 2024, Plant Doctor operates 4,328 stores, with approximately 88% being franchise stores, which has led to management challenges and quality control issues [1][3].

Core Viewpoint - Betaini's stock experienced a decline of 1.95% on November 21, with a trading volume of 229 million yuan, indicating a challenging market environment for the company [1] Financing and Margin Trading - On November 21, Betaini had a financing buy-in amount of 16.44 million yuan and a financing repayment of 31.40 million yuan, resulting in a net financing buy of -14.96 million yuan [1] - As of November 21, the total margin trading balance for Betaini was 663 million yuan, with a financing balance of 658 million yuan, accounting for 3.72% of the circulating market value, which is above the 80th percentile over the past year [1] - In terms of securities lending, Betaini repaid 200 shares and sold 100 shares on November 21, with a selling amount of 4,173 yuan, while the securities lending balance was 4.96 million yuan, also above the 90th percentile over the past year [1] Company Overview - Yunnan Betaini Biotechnology Group Co., Ltd. was established on May 13, 2010, and went public on March 25, 2021 [1] - The company focuses on skincare products under the "Winona" brand, emphasizing natural plant-based active ingredients for sensitive skin, with a revenue composition of 84.36% from skincare, 10.07% from makeup, 4.88% from medical devices, and 0.70% from services and others [1] Shareholder Information - As of November 10, the number of shareholders for Betaini was 39,700, an increase of 3.94% from the previous period, with an average of 10,681 circulating shares per person, a decrease of 3.79% [2] - For the period from January to September 2025, Betaini reported a revenue of 3.464 billion yuan, a year-on-year decrease of 13.78%, and a net profit attributable to shareholders of 272 million yuan, down 34.45% year-on-year [2] Dividend Distribution - Since its A-share listing, Betaini has distributed a total of 1.289 billion yuan in dividends, with 844 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the sixth-largest circulating shareholder, holding 5.8225 million shares, a decrease of 891,800 shares from the previous period [3] - E Fund's ChiNext ETF ranked seventh among circulating shareholders with 3.9167 million shares, down 660,600 shares, while Southern CSI 500 ETF ranked ninth with 2.5835 million shares, an increase of 101,900 shares [3]

Industry Overview - The cosmetics and medical beauty sector has shown stronger performance than the market, with the Shenwan Beauty Care Index declining by 4.5% from November 14 to November 21, 2025, outperforming the Shenwan A Index by 1.9 percentage points [3][4] - The cosmetics sales are expected to gradually decline as the peak shopping season ends, with domestic brands actively preparing new products for the off-season [9][10] Key Insights - The 2026 cosmetics and medical beauty strategy report indicates that brand growth is crucial, with upstream and downstream margins improving. Domestic brands are expected to grow against the trend during the industry consolidation phase [10][11] - The National Medical Products Administration has introduced 24 reform measures aimed at enhancing the regulatory framework for cosmetics, promoting high-quality industry development [26] Company Focus - Qingmu Technology (301110) is highlighted as a full-domain operation service expert, leveraging data and technology to drive growth. The company has established a strong brand matrix across various sectors, including fashion and beauty [15][16] - Investment recommendations include brands with strong channel and brand matrices such as Maogeping, Shangmei Co., and Proya, as well as companies in the medical beauty sector like Aimeike [12][14] Market Trends - The retail sales of cosmetics in October 2025 grew by 9.6%, driven by the Double 11 shopping festival, with a total retail sales of 381.3 billion yuan for cosmetics in the first ten months of 2025, reflecting a 4.6% year-on-year increase [21][23] - The domestic market for skincare products is expected to see further growth, with domestic brands gaining market share due to their competitive pricing and localized strategies [31][34]

Electricity Consumption - In October, total electricity consumption reached 857.2 billion kWh, a year-on-year increase of 10.4%[5] - The growth rates for the primary, secondary, and tertiary industries were 13.2%, 6.2%, and 17.1% respectively, with residential electricity consumption growing by 23.9%[5] - The tertiary industry and urban-rural residents contributed 5.9 percentage points to the overall electricity consumption growth[5] Employment Data - In September, the U.S. non-farm employment increased by 119,000, significantly exceeding the expected 51,000[7] - The unemployment rate in the U.S. reached 4.4%, the highest since October 2021, up from the previous value of 4.3%[7] Japan's Bond Yield - As of November 21, Japan's 10-year government bond yield rose to 1.8%, marking a significant increase and reaching levels not seen since 2008[17] - The 40-year bond yield peaked at 3.73%, while the 30-year yield reached 3.36%[17] China-Japan Relations - The Chinese Ministry of Culture and Tourism advised citizens to avoid traveling to Japan, impacting Japanese tourism and consumer stocks significantly[10] - China's suspension of Japanese seafood imports due to nuclear contamination concerns has led to a drastic drop in Japan's seafood export value to China, falling over 90% from 2022 levels[10] Youth Unemployment - In October, the unemployment rate for urban youth aged 16-24 was 17.3%, while the rate for those aged 25-29 was 7.2%[13] - The total estimated unemployed population in China for the 16-59 age group is approximately 41.95 million, with an overall estimate of around 45 million[13]

Investment Rating - The report maintains a "Positive" outlook on the beauty and personal care industry, highlighting robust demand and the continued rise of domestic brands [2]. Core Insights - The beauty care industry is experiencing a stable demand phase, with domestic leading brands expected to grow during the industry consolidation period [3]. - The cosmetics sector showed resilience during the off-peak season, with retail sales reaching 98.2 billion yuan from July to September, reflecting a single-digit year-on-year growth and an acceleration compared to the first half of 2025 [2][3]. - The report emphasizes the strong performance of domestic brands during the Double 11 shopping festival, with Proya ranking first in Tmall's beauty sales [2][11]. Summary by Sections Cosmetics Sector Performance - The cosmetics sector's key A-share companies reported an average revenue growth rate of around 3% in Q3 2025, with overall improvement in net profit [2]. - Proya's cumulative revenue for the first three quarters of 2025 was 7.098 billion yuan, a year-on-year increase of 1.89%, while its Q3 revenue was 1.736 billion yuan, down 11.63% year-on-year [16]. - Other notable performances include: - Ruifucheng: Q1-Q3 revenue of 2.138 billion yuan, up 85.3% year-on-year, with Q3 revenue of 819 million yuan, up 123.4% year-on-year [16]. - Marubi: Q1-Q3 revenue of 2.45 billion yuan, up 25.5% year-on-year, with Q3 revenue of 686 million yuan, up 14.28% year-on-year [16]. Medical Aesthetics Sector Performance - The medical aesthetics sector showed slight fatigue but experienced marginal improvements in Q3 2025 [2]. - Notable performances include: - Aimeike: Q1-Q3 revenue of 1.865 billion yuan, down 21.49% year-on-year, with Q3 revenue of 566 million yuan, down 21.27% year-on-year [2]. - Longzi: Q1-Q3 revenue of 4.328 billion yuan, up 0.9% year-on-year, with Q3 revenue of 1.539 billion yuan, up 11.9% year-on-year [2]. Investment Recommendations - The report recommends focusing on companies with a well-established channel and brand matrix, such as Maogeping, Shangmei, and Shanghai Jahwa, which are expected to see high GMV growth [2][20]. - Companies anticipated to show marginal improvements in performance include Proya, Marubi, and Ruifucheng [2]. - In the medical aesthetics sector, the report highlights Aimeike as a key recommendation, with Longzi suggested for further observation [2]. Market Trends - The domestic market share of leading brands is increasing, with the top ten domestic brands capturing 16.6% of the market share in skincare, up from 11.8% in 2023 [4]. - The report notes that the cosmetics retail sales in October 2025 grew by 9.6% year-on-year, indicating a recovery in demand driven by promotional events [10][11].